Anxiety disorders have emerged as global neurological disorders with serious detrimental effects, while dietary supplementation offers new insights for alleviating them. Although bioactive peptides have demonstrated anxiolytic properties, a systematic comparison between low-molecular-weight soybean peptides (SPep) and intact soybean proteins (SPro) through nutritional interventions remains unexplored. This study evaluated the effects of SPro and SPep nutritional interventions on anxiety-like behaviors induced by chronic unpredictable mild stress in mice, exploring their underlying mechanisms. The results revealed that both SPro and SPep nutritional interventions increased glutamate and glutamine levels in mouse brain tissue, but only the SPep diet was effective in alleviating anxiety-like behaviors and reducing c-Fos expression. Distinct alterations in gut microbiota composition were observed for each diet, with the SPep diet notably increasing the relative abundance of Bacteroidales and Lachnospiraceae, and elevating isobutyric acid, valeric acid, and isovaleric acid levels. Additionally, the SPep diet significantly reduced corticosterone levels and specifically modulated the StAR gene, contributing to the normalization of the hypothalamic-pituitary-adrenal (HPA) axis. Importantly, correlation analysis underscored the critical roles of the gut-brain and HPA axes. Collectively, these findings suggest that the SPep diet exerts its anxiolytic effects primarily through the gut-brain axis, with the HPA axis serving as the central regulatory mechanism.

Globally, the prevalence of anxiety and depression has reached epidemic proportions. Food-derived protein hydrolysates and peptides delivered through dietary supplementation can avoid the negative risks associated with traditional pharmaceuticals while delivering superior anxiolytic and antidepressant effects. This review summarizes current research on food-derived anxiolytic and antidepressant protein hydrolysates and peptides, and subsequently analyses their physicochemical characteristics and elaborates on their mechanisms. The aim of this work is to contribute to the in-depth study and provide a theoretical foundation for the development of related products to better serve patients with anxiety and depression.

Trimethyltin chloride (TMT) is a potent neurotoxin to cause neurodegeneration, especially in hippocampus. This study aimed to identify dietary components that can effectively attenuate TMT-induced neurodegeneration in humans. The predominant anthocyanin in human diets, cyanidin-3-O-glucoside (C3G, 5 or 50 mg/kg), was given to mice for 16 days, and TMT (2.7 mg/kg) was injected intraperitoneally once on the eighth day. C3G (50 mg/kg) significantly alleviated TMT-induced seizures and subsequent cognitive impairment by ameliorating hippocampal neurodegeneration and synaptic dysfunction. Furthermore, C3G treatment restored glutamate homeostasis in brain and reversed glutamine synthetase (GS) inhibition in reactive astrogliosis and neuroinflammation, which are critical for C3G’s neuroprotective effects. Notably, C3G decreased the lipopolysaccharide, tumor necrosis factor-α, interleukin-6, and interleukin-1β levels in the mice, which potentially by modulating the relative abundance of Atopobiaceae and Lachnospiraceae in the gut. C3G may be a promising and practical dietary component for reducing TMT-induced neurodegeneration.